Uses of Europanta

Europanta drug belongs to the group of drugs for the gastrointestinal tract. The following article provides information on the uses, doses and precautions when using Europanta.

Europanta drug has the main ingredient is Pantoprazole, is prepared in the form of enteric coated tablets, packed in boxes of 3 blisters x 10 tablets. Indications for use of Europanta drug in the following cases:
People with gastroesophageal reflux disease - oesophagitis; People with gastrointestinal ulcers; Effective in preventing ulcers caused by non-steroidal anti-inflammatory drugs; Use in the presence of pathological hypersecretion in Zollinger Ellison syndrome.

Dosage:
For patients treating gastroesophageal reflux syndrome: The common dose will be 20-40mg x 1 time / day, used for 4 weeks or can last up to 8 weeks. The maintenance dose is 20-40mg/day. If relapse use dose 20mg/day; For patients treated for peptic ulcer: The usual dose is 40mg x 1 time/day, used for 2-4 weeks for duodenal ulcer, 4-8 weeks for benign gastric ulcer; For people who want to eradicate Helicobacter pylori: Use a 1-week triple combination therapy regimen with a dose of Pantoprazol 40 mg x 2 times/day, in combination with clarithromycin 500mg x 2 times/day and amoxicillin 1g x 2 times/day or metronidazole 400mg x 2 times/day; In case you want to prevent ulcers caused by non-steroidal anti-inflammatory drugs: Use a dose of 20mg/day; In the treatment of Zollinger - Ellison syndrome: The starting dose is 80mg/day or 240mg/day. Using a dose of over 80mg/day, the patient should be divided into 2 doses; For patients with liver failure: Use a maximum dose of 20mg/day or 40mg/day - use every other day; For patients with renal impairment: Use a maximum dose of 40mg/day. How to use:
Europanta tablets take 1 time in the morning, swallow whole and do not chew / crush the drug.

Contraindications:
Do not use with people who are hypersensitive to any component of the drug or other benzimidazole derivatives such as: esomeprazole, lansoprazol, omeprazol, rabeprazol; Women who are pregnant and breastfeeding. Side effects:
Common: Digestive disorders such as diarrhea, nausea or headache; Uncommon:
Effects on the nervous system: Sleep disturbance, dizziness; Effects on the digestive system: Abdominal pain, flatulence, constipation, dry mouth, increased liver enzymes, vomiting; Effects on dermatology and soft tissue: Appearance of skin rash, exanthema, rash; Systemic effects: Body weakness, fatigue, feeling malaise. Caution:
Treatment time of day: Slightly increased risk of hip, wrist, spine fractures. This risk is more common in the elderly or people with other risk factors; The risk of osteoporosis may occur and the patient should be monitored, supplemented with vitamin D, calcium accordingly; Treatment for 3 consecutive months or 1 year can cause severe hypomagnesaemia; It is important to note that magnesium levels should be measured before initiating therapy and periodically during treatment in patients requiring long-term therapy or requiring proton pump inhibitors in combination with digoxin or other hypomagnesaemic agents such as Diuretic; Even the body's response to treatment with Pantoprazol does not prevent the progression of stomach tumors; It is important to exclude the possibility of a malignant peptic ulcer before taking the drug because pantoprazole may mask symptoms thereby delaying the diagnosis; Cases of mild and transient elevations in serum ALT (SGPT) have been reported during treatment with oral pantoprazole; Poor absorption of cyanocobalamin; Daily treatment with acid-suppressing agents for a long time (eg, more than 3 years) may reduce cyanocobalamin absorption leading to decreased gastric acidity or gastric acidosis; The drug has not been adequately studied for its safety in children under 18 years of age; The drug has not been adequately studied for its safety in pregnant or lactating women; The drug may affect the ability to drive and use machines due to side effects such as dizziness and visual disturbances, should be used with caution. Drug Interactions: Drugs that depend on gastric acid pH, such as ketoconazole.
It is hoped that with the synthesis of information about the drug Europanta, it will help the process of using the drug in patients effectively, safely and bring good effects to the treatment process.